Beyond the brain: widespread pathology in Huntington's disease

被引:258
|
作者
van der Burg, Jorien M. M. [1 ]
Bjorkqvist, Maria [1 ]
Brundin, Patrik [1 ]
机构
[1] Lund Univ, Neuronal Survival Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, S-22184 Lund, Sweden
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 08期
基金
瑞典研究理事会;
关键词
TRANSGENIC MOUSE MODEL; CHOLESTEROL-BIOSYNTHESIS PATHWAY; PITUITARY-ADRENAL AXIS; PERIPHERAL-BLOOD CELLS; EXPANDED CAG REPEAT; R6/2; MOUSE; GENE-EXPRESSION; WEIGHT-LOSS; INCREASED APOPTOSIS; DIABETES-MELLITUS;
D O I
10.1016/S1474-4422(09)70178-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by a polyglutamine stretch in the huntingtin protein. Today, more than 15 years after the genetic defect underlying HD was discovered, the pathogenesis is still not well understood and there is no adequate treatment. Research into this disorder has conventionally focused on neurological symptoms and brain pathology, particularly neurodegeneration in the basal ganglia and cerebral cortex. Mutant huntingtin is, however, ubiquitously expressed throughout the body. Indeed, contrary to earlier thinking, HD is associated with abnormalities in peripheral tissues. These abnormal changes are not all secondary to brain dysfunction, but most seem to be directly caused by expression of mutant huntingtin in peripheral tissues. In this article, we highlight this emerging field of research and how it might affect our understanding of the pathogenesis of this disease, the development of novel biomarkers of disease progression, and the identification of new potential treatments.
引用
收藏
页码:765 / 774
页数:10
相关论文
共 50 条
  • [31] Huntington's Disease: Looking Beyond the Movement Disorder
    Morreale, Mary K.
    CLINICAL CHALLENGES IN THE BIOPSYCHOSOCIAL INTERFACE: UPDATE ON PSYCHOSOMATICS FOR THE 21ST CENTURY, 2015, 34 : 135 - 142
  • [32] Pridopidine in treatment of Huntington's disease: beyond chorea?
    Feigin, Andrew
    LANCET NEUROLOGY, 2011, 10 (12): : 1036 - 1037
  • [33] Genetic modifiers of Huntington's disease: beyond CAG
    Arning, Larissa
    Epplen, Joerg T.
    FUTURE NEUROLOGY, 2012, 7 (01) : 93 - 111
  • [34] Beyond The Movement Disorder : OCD in Huntington's Disease
    Neeharika, Sagi Lakshmi
    Reddy, Suresh
    Surekha, G.
    Pradyumna, C.
    INDIAN JOURNAL OF PSYCHIATRY, 2025, 67 : S188 - S188
  • [35] Huntington’s disease: A decade beyond gene discovery
    Penelope Hogarth
    Current Neurology and Neuroscience Reports, 2003, 3 (4) : 279 - 284
  • [36] Brain energy metabolism in Huntington's disease
    Wieler, M
    Hanstock, C
    Martin, W
    MOVEMENT DISORDERS, 2004, 19 : S372 - S372
  • [37] Huntington disease pathology unfolds
    Lewis, R
    SCIENTIST, 2003, 17 (10): : 32 - 33
  • [38] Brain Microbiota in Huntington's Disease Patients
    Alonso, Ruth
    Pisa, Diana
    Carrasco, Luis
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [39] Brain structure in preclinical Huntington's disease
    Paulsen, JS
    Magnotta, VA
    Mikos, AE
    Paulson, HL
    Penziner, E
    Andreasen, NC
    Nopoulos, PC
    BIOLOGICAL PSYCHIATRY, 2006, 59 (01) : 57 - 63
  • [40] Deep brain stimulation in Huntington's disease
    Bonomo, Roberta
    Elia, Antonio
    Bonomo, Giulio
    Romito, Luigi
    Mariotti, Caterina
    Devigili, Grazia
    Cilia, Roberto
    Giossi, Riccardo
    Eleopra, Roberto
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 344 - 345